Loading
companiesCompany
Atlas Venture
A Cambridge, Massachusetts biotech-only venture firm that seeds and incubates new drug companies. Cancer companies it has built include Bicycle Therapeutics, Day One Biopharmaceuticals and Antares Therapeutics.
Overview
Atlas Venture dates from 1980 (Wikipedia) and today describes itself as having created and built biotech companies for over 30 years, with an in-house incubator that has launched 92 start-ups and produced 43 IPOs and 39 M&A exits according to its homepage. It leads seed and Series A rounds, often forming companies around a single academic insight. The portfolio page lists many oncology companies: Accent Therapeutics (RNA-modifying protein inhibitors for cancer), Antares Therapeutics (first-in-class precision medicines for cancer, the subject of a Novartis deal), Bicycle Therapeutics (bicyclic peptide drug conjugates, Nasdaq: BCYC), Day One Biopharmaceuticals (Nasdaq: DAWN), IFM Therapeutics (innate immunity for cancer, sold to BMS and Novartis), Ikena Oncology and K36 Therapeutics.
Portfolio (6)
Filter the startups table| Company | Stage | Type | Cancers | Latest round |
|---|---|---|---|---|
| K36 Therapeutics Cambridge, MA, US | Startup | biotech | Multiple myelomaProstate cancer | Series B 2023, $70M |
| Mariana Oncology Watertown, MA, US | Acquired | radiopharma | Small-cell lung cancer | Acquisition 2024, $1B |
| Nimbus Therapeutics Boston, MA, US | Growth stage | biotech | Crossover 2023, $210M | |
| Obsidian Therapeutics Cambridge, MA, US | Public | cell therapy | MelanomaNon-small-cell lung cancer | Crossover 2026, $350M |
| Pheon Therapeutics London, GB | Startup | biotech | Series B 2024, $120M | |
| Triana Biomedicines Lexington, MA, US | Startup | biotech | Non-small-cell lung cancerHR-positive / HER2-negative breast cancer | Series B 2025, $120M |
Similar pages
- CompanyForbion
Shares Mariana Oncology, Pheon Therapeutics and the tag vc.
- CompanyTCGX (TCG Crossover)
Shares Pheon Therapeutics, Obsidian Therapeutics and the tag vc.
- CompanyLightspeed Venture Partners
Shares Pheon Therapeutics, Triana Biomedicines and the tag vc.
- CompanyLogos Capital
Shares Obsidian Therapeutics, Triana Biomedicines and the tag vc.
- CompanyRA Capital Management
Shares Mariana Oncology, Obsidian Therapeutics, Triana Biomedicines and the tag vc.
- CompanyF-Prime Capital
Shares K36 Therapeutics and the tag vc.
- CompanyPerceptive Advisors
Shares Pheon Therapeutics and the tag vc.
- CompanySR One
Shares Nimbus Therapeutics and the tag vc.